title: Diabetic ketoacidosis.
abstract: In the past decade, considerable advances have occurred in our understanding of the pathophysiology of this disorder, its metabolic sequelae, and its management, particularly with respect to continuous low-dose insulin infusion and the potential benefits of phosphate. This article reviews these advances as they pertain to children.
mesh_terms: D001639:Bicarbonates / Q000627:therapeutic use; D001929:Brain Edema / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D016883:Diabetic Ketoacidosis / Q000150:complications / Q000503:physiopathology* / Q000628:therapy; D004837:Epinephrine / Q000378:metabolism; D005440:Fluid Therapy; D005934:Glucagon / Q000378:metabolism; D013006:Growth Hormone / Q000378:metabolism; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism; D007328:Insulin / Q000378:metabolism / Q000627:therapeutic use; D000078790:Insulin Secretion; D007657:Ketone Bodies / Q000378:metabolism; D010710:Phosphates / Q000627:therapeutic use; D014882:Water-Electrolyte Balance
chemical_list: D001639:Bicarbonates; D007328:Insulin; D007657:Ketone Bodies; D010710:Phosphates; D013006:Growth Hormone; D005934:Glucagon; D006854:Hydrocortisone; D004837:Epinephrine